Table 1.

Previous reports of porokeratosis in patients with prostate cancer.

Author (Year)	Ref.	Porokeratosis subtype	Age	Cancer duration	Cancer treatment	Treatment	Outcome
O’Donnell et al. (1992)	4	DSAP	NR	NR	Suramin	NR	NR
Batchelor et al. (2010)	7	LP	NR	6 years	Radiotherapy, bicalutamide, leupror	elin Liquid nitrogen cryotherapy	Complete resolution
Shah et al. (2018)	8	LP	68	NR	Radiotherapy	Topical imiquimod and cryotherapy	Complete resolution
Itoi-Ichi et al. (2020)	6	GP + DSAP	66	4 years	NR	Topical steroids, oral etretinate & antiallergic agents	Partial response
Hsueh YT, et al. (2020)	3	DSAP	NR	NR	NR	NR	NR

NR, not reported; DSAP, diffuse superficial actinic porokeratosis; GP, giant porokeratosis; LP, localized porokeratosis.